CWM
MRNA icon

Castle Wealth Management’s Moderna MRNA Stock Holding History

Castle Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-518
Closed -$61K – 423
2022
Q3 		$61K Hold
518
– – 0.04% 191
2022
Q2 		$74K Buy
+518
New +$74K 0.04% 174

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Castle Wealth Management's MRNA Position: Q4 2022 in Review

Castle Wealth Management sold out of Moderna (MRNA) in Q4 2022, closing a stake of 518 shares — an estimated $61K sold.

Castle Wealth Management first reported a position in MRNA in Q2 2022 and held it in 2 quarters. The position peaked at $74K in Q2 2022. 1,071 funds tracked by Wall St. Rank hold MRNA as of Q4 2022.

  • Castle Wealth Management reported no remaining Moderna position as of Q4 2022 after selling out during the quarter.
  • Castle Wealth Management sold 518 Moderna shares in Q4 2022, an estimated $61K.
  • Castle Wealth Management first reported a position in Moderna in Q2 2022 and held it in 2 quarters.
  • Castle Wealth Management's Moderna position peaked at $74K in Q2 2022.
  • 1,071 funds tracked by Wall St. Rank held Moderna as of Q4 2022.

Based on Castle Wealth Management's 13F filing for Q4 2022, filed 9 Feb 2023.